Qingfeng Ni

833 total citations
32 papers, 586 citations indexed

About

Qingfeng Ni is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qingfeng Ni has authored 32 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Qingfeng Ni's work include MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (8 papers) and RNA modifications and cancer (4 papers). Qingfeng Ni is often cited by papers focused on MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (8 papers) and RNA modifications and cancer (4 papers). Qingfeng Ni collaborates with scholars based in China, Denmark and India. Qingfeng Ni's co-authors include Jiawei Yu, Lianbao Kong, Wei Hsian Yin, Liangliang Kong, Yan Zhang, Peisheng Chen, Wenzhou Ding, Xiaolong Li, Jianwei Zhu and Weiwei Jiang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Qingfeng Ni

31 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingfeng Ni China	15	334	256	113	101	98	32	586
Xiaopin Ji China	15	301 0.9×	183 0.7×	197 1.7×	105 1.0×	69 0.7×	31	584
Rosemary Jeffery United Kingdom	14	326 1.0×	211 0.8×	214 1.9×	166 1.6×	89 0.9×	18	715
Jiabo Di China	15	286 0.9×	168 0.7×	237 2.1×	47 0.5×	70 0.7×	39	578
Enhao Zhao China	16	412 1.2×	335 1.3×	162 1.4×	63 0.6×	196 2.0×	25	715
Tamako Konkin United States	7	319 1.0×	213 0.8×	233 2.1×	126 1.2×	44 0.4×	8	762
Derek Yau China	8	204 0.6×	139 0.5×	152 1.3×	46 0.5×	107 1.1×	12	541
Masahisa Ohtsuka Japan	11	367 1.1×	317 1.2×	136 1.2×	97 1.0×	31 0.3×	48	574
Binghua Dai China	16	397 1.2×	327 1.3×	127 1.1×	60 0.6×	32 0.3×	30	624
Yilin Hu China	13	555 1.7×	472 1.8×	84 0.7×	44 0.4×	60 0.6×	32	710
Bangrong Cao China	14	564 1.7×	376 1.5×	167 1.5×	85 0.8×	133 1.4×	44	818

Countries citing papers authored by Qingfeng Ni

Since Specialization

Citations

This map shows the geographic impact of Qingfeng Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Ni more than expected).

Fields of papers citing papers by Qingfeng Ni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfeng Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Ni. The network helps show where Qingfeng Ni may publish in the future.

Co-authorship network of co-authors of Qingfeng Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfeng Ni. A scholar is included among the top collaborators of Qingfeng Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfeng Ni. Qingfeng Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ni, Qingfeng, Yuanjie Niu, Zhenwei Han, et al.. (2025). Single-cell transcriptomic data reveal the cellular heterogeneity of glutamine metabolism in gastric premalignant lesions and early gastric cancer. Acta Biochimica et Biophysica Sinica. 57(10). 1670–1683.

Qiu, Xingfeng, Yan‐Lai Tang, Libin Huang, et al.. (2025). Cystine-Modified Lignin–Copper Coordination Nanocarriers Improve the Therapeutic Efficacy of Tyrosine Kinase Inhibition via Cuproptosis. ACS Applied Materials & Interfaces. 17(6). 9074–9086. 1 indexed citations

Ni, Qingfeng, Hai Zhang, Xiaoli Shi, & Xiangcheng Li. (2023). Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway. Cancer Gene Therapy. 30(4). 582–595. 26 indexed citations

Wang, Peng, Mingjie Xie, Wei Xu, et al.. (2022). The Number of Lymph Nodes Examined is Associated with Survival Outcomes of Neuroendocrine Tumors of the Jejunum and Ileum (siNET): Development and Validation of a Prognostic Model Based on SEER Database. Journal of Gastrointestinal Surgery. 26(9). 1917–1929. 3 indexed citations

Yu, Hong, et al.. (2021). Protective effects of upregulated HO-1 gene against the apoptosis of human retinal pigment epithelial cells in vitro. International Journal of Ophthalmology. 14(5). 649–655. 6 indexed citations

Zhang, Yan, Dong Tang, Xiaolong Li, et al.. (2021). Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway. Acta Biochimica et Biophysica Sinica. 53(11). 1547–1557. 8 indexed citations

Ni, Qingfeng, et al.. (2021). MicroRNA-92b augments sorafenib resistance in hepatocellular carcinoma via targeting PTEN to activate PI3K/AKT/mTOR signaling. Brazilian Journal of Medical and Biological Research. 54(9). e10390–e10390. 6 indexed citations

Zhang, Yan, et al.. (2020). MiR-660-5p promotes the progression of hepatocellular carcinoma by interaction with YWHAH via PI3K/Akt signaling pathway. Biochemical and Biophysical Research Communications. 531(4). 480–489. 26 indexed citations

Yu, Jiawei, et al.. (2020). MicroRNA-92a promotes proliferation and invasiveness of gastric cancer cell by targeting FOXO1 gene. Cellular and Molecular Biology. 66(1). 95–100. 4 indexed citations

10.

Yu, Jiawei, Qingfeng Ni, Xiaofei Zhi, et al.. (2019). Syndecan-2 in colorectal cancer plays oncogenic role via epithelial-mesenchymal transition and MAPK pathway. Biomedicine & Pharmacotherapy. 121. 109630–109630. 45 indexed citations

11.

Zhang, Yan, et al.. (2017). Nectin-4 promotes gastric cancer progression via the PI3K/AKT signaling pathway. Human Pathology. 72. 107–116. 48 indexed citations

12.

Zhi, Xiaofei, Baofei Jiang, Oluf Dimitri Røe, et al.. (2016). Prognostic role of microscopically positive margins for primary gastrointestinal stromal tumors: a systematic review and meta-analysis. Scientific Reports. 6(1). 21541–21541. 25 indexed citations

13.

Ding, Wenzhou, et al.. (2015). MicroRNA-497 regulates cell proliferation in hepatocellular carcinoma. Oncology Letters. 11(2). 1081–1088. 11 indexed citations

14.

Ni, Qingfeng, et al.. (2015). Cortactin promotes colon cancer progression by regulating ERK pathway. International Journal of Oncology. 47(3). 1034–1042. 27 indexed citations

15.

Xu, Lin, Xiang Ding, Qingfeng Ni, & Shaoju Jin. (2015). Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.. PubMed. 8(7). 7937–44. 7 indexed citations

16.

Jiang, Weiwei, et al.. (2014). The microRNA‐146a/b attenuates acute small‐for‐size liver graft injury in rats. Liver International. 35(3). 914–924. 14 indexed citations

17.

Ni, Qingfeng, et al.. (2014). Latexin exhibits tumor suppressor potential in hepatocellular carcinoma. Oncology Reports. 31(3). 1364–1372. 20 indexed citations

18.

Jiang, Weiwei, Liangliang Kong, Qingfeng Ni, et al.. (2014). miR-146a Ameliorates Liver Ischemia/Reperfusion Injury by Suppressing IRAK1 and TRAF6. PLoS ONE. 9(7). e101530–e101530. 80 indexed citations

19.

Tian, Yuan, Changjun Huang, Qingfeng Ni, et al.. (2013). CDCA7L promotes hepatocellular carcinoma progression by regulating the cell cycle. International Journal of Oncology. 43(6). 2082–2090. 15 indexed citations

20.

Ni, Qingfeng, Guoqing Liu, Liyong Pu, Liangliang Kong, & Lianbao Kong. (2013). Dermatomyositis associated with gallbladder carcinoma: A case report. World Journal of Hepatology. 5(4). 230–230. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact